Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Claud B who wrote (4003)	5/8/1998 7:18:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Welcome back, Claud. Nice that you couldn't stay away! Goldstein is an unusual fellow, judging from what I recall was said about him on the VVUS thread a long time ago. I don't know how reliable he is, based on what was said there at that time. But we'll see. Let's set that aside and focus on what you tell us he said. When he said that Vasomax should be first line of therapy for Viagra failures, did he say that he tested on Viagra failures and if so, what percentage was helped? It is an easy thing to say but not necessarily accurate, because Viagra works on people with a wide range of problems, even severe, while Vasomax is presented by Dr. Goldstein only for MINIMAL dysfunction. As a result, to use Vasomax for all those who failed with Viagra, would be including a huge percentage who would be automatically eliminated by the screening criteria for Vasomax. Linda